Autopsy report · NCT04549584

Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer

“due to poor enrolled patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Seoul National University Hospital

Sponsor type

University, hospital or other

Conditions

Metaplastic Breast Carcinoma

Interventions

Vimentin/pan CK stain

Participants

3

Sites

1

Countries

South Korea

Trials that died the same way

• Wellness Initiative at New York University
  “Due to inability to enroll patients” (82% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (80% match in meaning)
• Study of Image-Guided SBRT for Vertebral Metastases
  “not sufficient patients enrolled” (78% match in meaning)
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
  “no enough enrolled patients” (77% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.